TrialThe Lancet. Oncology2021

PET-guided omission of radiotherapy in early-stage unfavourable Hodgkin lymphoma (GHSG HD17): a multicentre, open-label, randomised, phase 3 trial.

Peter Borchmann et al.PubMed ↗Publisher ↗

No numbers read from the abstract.